SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CICCONE, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.357
AS - Asia 1.902
EU - Europa 1.303
SA - Sud America 281
AF - Africa 26
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.876
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.270
SG - Singapore 768
CN - Cina 648
DE - Germania 339
BR - Brasile 231
UA - Ucraina 202
GB - Regno Unito 165
IT - Italia 164
HK - Hong Kong 149
TR - Turchia 134
FI - Finlandia 98
VN - Vietnam 96
SE - Svezia 72
RU - Federazione Russa 66
FR - Francia 55
CA - Canada 46
MX - Messico 33
PL - Polonia 31
IN - India 30
CZ - Repubblica Ceca 25
AR - Argentina 21
BE - Belgio 20
ES - Italia 17
ID - Indonesia 17
NL - Olanda 16
JP - Giappone 15
ZA - Sudafrica 14
LT - Lituania 12
EC - Ecuador 11
IQ - Iraq 10
BD - Bangladesh 9
AT - Austria 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
IL - Israele 4
IR - Iran 4
MA - Marocco 4
RO - Romania 4
VE - Venezuela 4
AU - Australia 3
CH - Svizzera 3
KR - Corea 3
PY - Paraguay 3
BG - Bulgaria 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IE - Irlanda 2
KE - Kenya 2
MY - Malesia 2
PK - Pakistan 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GF - Guiana Francese 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
SR - Suriname 1
TO - Tonga 1
UZ - Uzbekistan 1
Totale 7.876
Salva come PNG Salva come JPEG
Città #
Woodbridge 466
Singapore 446
Ashburn 439
Fairfield 391
Houston 318
Beijing 272
Chandler 258
Jacksonville 224
Santa Clara 202
Ann Arbor 179
Seattle 160
Hong Kong 148
Cambridge 147
Wilmington 136
Los Angeles 110
New York 100
Munich 87
Dallas 76
Nanjing 71
Izmir 68
Princeton 53
Ferrara 50
Shanghai 50
Boardman 40
San Diego 40
Addison 37
Milan 35
Turku 32
Ho Chi Minh City 30
São Paulo 29
Warsaw 29
Shenyang 26
Bremen 25
London 24
Buffalo 22
Helsinki 21
Mexico City 21
Brussels 20
Nanchang 20
Montreal 19
Hanoi 17
Stockholm 17
Poplar 16
Hebei 15
Brno 14
Denver 14
Hefei 14
Brooklyn 13
Falkenstein 13
Frankfurt am Main 13
Changsha 12
Chennai 12
Chicago 12
Jinan 12
Manchester 12
San Francisco 12
Tokyo 12
Jakarta 11
Johannesburg 11
Tianjin 11
Auburn Hills 10
Augusta 10
Olomouc 10
Rio de Janeiro 10
Moscow 9
San Jose 9
Toronto 9
Zhengzhou 9
Atlanta 8
Orange 8
Bologna 7
Boston 7
Dearborn 7
Haiphong 7
Jiaxing 7
Mumbai 7
Nuremberg 7
Orem 7
Ottawa 7
Phoenix 7
San Mateo 7
Ankara 6
Guangzhou 6
Guayaquil 6
Biên Hòa 5
Falls Church 5
Mountain View 5
Norwalk 5
Redwood City 5
Washington 5
Baghdad 4
Columbus 4
Leawood 4
Minerbe 4
Philadelphia 4
Querétaro 4
Raleigh 4
Redmond 4
Vancouver 4
Amsterdam 3
Totale 5.440
Salva come PNG Salva come JPEG
Nome #
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 237
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 230
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 215
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 214
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 212
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 211
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 210
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 207
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 202
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 192
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 191
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 190
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 189
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 184
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 183
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 182
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 181
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 178
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 177
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 175
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 171
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 168
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 168
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 168
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 167
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 165
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 165
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 159
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 158
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 157
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 157
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 154
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 152
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 142
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 142
Neoplastic circulating endothelial cells in hematologic malignancies 142
Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia 138
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 131
Molecular cytogenetic lesions in chronic lymphocytic leukemia 128
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups. 124
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 117
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 111
Significato dell'analisi citogenetica e citogenetico-molecolare nella diagnosi e nella prognosi delle neoplasie ematologiche. Cytogenetics and molecular cytogenetics in diagnosis and prognosis of haematological malignancies 106
TRISOMY 8 IN PDGFRB-NEGATIVE CELLS IN A PATIENT WITH IMATINIB SENSITIVE CHRONIC MYELOMONOCYTIC LEUKAEMIA AND THE T(5;16)(Q33;P13)/PDGFRB/NDE1 FUSION 101
Neoplastic circulating endothelial cells in hematologic malignancies 88
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 71
Neoplastic circulating endothelial cells in hematologic malignancies. 68
null 59
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 55
null 55
rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors’ response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow sample. 55
null 45
Totale 7.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 555
Totale 36.071
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021456 0 0 0 0 0 85 22 74 7 86 126 56
2021/2022579 57 68 32 16 29 23 24 18 11 46 56 199
2022/2023562 55 31 24 69 111 73 31 55 60 5 26 22
2023/2024277 28 37 10 7 11 56 12 22 7 6 6 75
2024/20251.276 16 42 91 51 170 149 13 44 201 105 197 197
2025/20262.056 400 166 284 534 619 53 0 0 0 0 0 0
Totale 7.947